InvestorsHub Logo

RMacchio

01/23/22 9:33 PM

#3249 RE: DollarSquad #3248

"but it's not as good"


If you read the announcement you would see that Rockley only passed the first phase - blood pressure measurements. They haven't completed testing for the other biomarkers. In the end, maybe it won't be accurate enough for a CGM medical device. We'll find out.